| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695663 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
This prospective trial demonstrated that SLN biopsy plus side-specific LAD, when SLN is not detected, is a reasonable alternative to a complete LAD in high-risk endometrial cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Pamela T. Soliman, Shannon N. Westin, Shayan Dioun, Charlotte C. Sun, Elizabeth Euscher, Mark F. Munsell, Nicole D. Fleming, Charles Levenback, Michael Frumovitz, Pedro T. Ramirez, Karen H. Lu,